Publication | Closed Access

Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients

MedicinePharmacologyCyp GenotypeClinical PharmacologyPharmacotherapyCancer PatientsMetabolomicsOncologyRadiation OncologyPharmacokineticsCancer ResearchInflammatory MarkersTranslational Pharmacology